相似文献
1
Breastfeeding in patients with Gaucher disease: Is taliglucerase alfa safe?
Mol Genet Metab Rep. 2019 Jan 16;18:30-31. doi: 10.1016/j.ymgmr.2018.11.004. eCollection 2019 Mar.
2
Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naïve or previously treated with imiglucerase.
Blood Cells Mol Dis. 2018 Feb;68:163-172. doi: 10.1016/j.bcmd.2016.10.005. Epub 2016 Oct 20.
3
Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease.
Orphanet J Rare Dis. 2018 Feb 23;13(1):36. doi: 10.1186/s13023-018-0776-8.
4
Spotlight on taliglucerase alfa in the treatment of pediatric patients with type 1 Gaucher disease.
Pediatric Health Med Ther. 2017 Jun 16;8:73-81. doi: 10.2147/PHMT.S93634. eCollection 2017.
5
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase.
Am J Hematol. 2016 Jul;91(7):661-5. doi: 10.1002/ajh.24399. Epub 2016 May 18.
6
Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher disease.
Blood Cells Mol Dis. 2019 Sep;78:14-21. doi: 10.1016/j.bcmd.2016.07.002. Epub 2016 Jul 18.
7
Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease.
Blood Cells Mol Dis. 2015 Jan;54(1):9-16. doi: 10.1016/j.bcmd.2014.10.002. Epub 2014 Nov 7.
8
Taliglucerase alfa in Gaucher disease: Description of a Brazilian experience.
Blood Cells Mol Dis. 2018 Feb;68:160-162. doi: 10.1016/j.bcmd.2017.01.005. Epub 2017 Jan 16.
9
Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease.
Am J Hematol. 2016 Jul;91(7):656-60. doi: 10.1002/ajh.24369. Epub 2016 Apr 24.
10
Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfa.
J Inherit Metab Dis. 2018 Nov;41(6):1259-1265. doi: 10.1007/s10545-018-0195-y. Epub 2018 Jul 31.
引用本文的文献
1
Serum hepcidin as a biomarker of treatment response in Gaucher disease.
Mol Genet Metab Rep. 2025 Sep 24;45:101255. doi: 10.1016/j.ymgmr.2025.101255. eCollection 2025 Dec.
本文引用的文献
1
Breastfeeding in Gaucher disease: is enzyme replacement therapy safe?
Clin Ther. 2014 Jun 1;36(6):990-1. doi: 10.1016/j.clinthera.2014.03.017. Epub 2014 Apr 24.
2
Successful pregnancy and lactation outcome in a patient with Gaucher disease receiving enzyme replacement therapy, and the subsequent distribution and excretion of imiglucerase in human breast milk.
Clin Ther. 2010 Nov;32(12):2048-52. doi: 10.1016/j.clinthera.2010.11.008.
3
Bone mineral changes during pregnancy and lactation.
Endocrine. 2002 Feb;17(1):49-53. doi: 10.1385/ENDO:17:1:49.
4
Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
Arch Biochem Biophys. 1976 Aug;175(2):569-82. doi: 10.1016/0003-9861(76)90547-6.
Zotero 插件